Cui Junling, Wang Yuanyuan, Zhang Huifeng, Cui Xiaopu, Wang Lihui, Zheng Huacheng
Department of Neurosurgery, The Second Hospital of Hebei Medical University.
Second Department of Neurology, The Children's Hospital of Hebei Province.
Medicine (Baltimore). 2019 Sep;98(39):e17334. doi: 10.1097/MD.0000000000017334.
Subacute combined degeneration (SCD) is a disease caused by decreased vitamin B12 intake or metabolic disorders. It is more common in the elderly and rarely seen in children. Here, we report 2 pediatric cases of SCD in late-onset cobalamin C (CblC) deficiency.
The patients complained of unsteady gait. Their physical examination showed sensory ataxia. Magnetic resonance imaging showed classic manifestations of SCD. The serum vitamin B12 level was normal, but urine methylmalonic acid and serum homocysteine levels were high.
The pathogenic gene was confirmed as MMACHC. The 2 patients each had 2 pathogenic mutations C.482 G>A and C.271dupA and C.365A>T and C.609G>A in this gene. They were diagnosed with combined methylmalonic acidemia and homocysteinemia-CblC subtype.
The patients were treated with methylcobalamin 500 μg intravenous injection daily after being admitted. After the diagnosis, levocarnitine, betaine, and vitamin B12 were added to the treatment.
Twelve days after treatment, the boy could walk normally, and his tendon reflex and sense of position returned to normal. The abnormal gait seemed to have become permanent in the girl and she walked with her legs raised higher than normal.
To the best of our knowledge, this is the first report of 2 cases of isolated SCD in children with late-onset CblC disorder. Doctors should consider that SCD could be an isolated symptom of CblC disorder. The earlier the treatment, the lower the likelihood of sequelae.
亚急性联合变性(SCD)是一种由维生素B12摄入减少或代谢紊乱引起的疾病。它在老年人中更为常见,在儿童中很少见。在此,我们报告2例迟发性钴胺素C(CblC)缺乏导致的小儿SCD病例。
患者主诉步态不稳。体格检查显示感觉性共济失调。磁共振成像显示SCD的典型表现。血清维生素B12水平正常,但尿甲基丙二酸和血清同型半胱氨酸水平升高。
致病基因被确认为MMACHC。这2例患者在该基因中分别有2个致病突变,即C.482 G>A和C.271dupA以及C.365A>T和C.609G>A。他们被诊断为甲基丙二酸血症和高同型半胱氨酸血症-CblC亚型。
患者入院后每天接受500μg甲钴胺静脉注射治疗。确诊后,治疗中添加了左卡尼汀、甜菜碱和维生素B12。
治疗12天后,男孩能够正常行走,其腱反射和位置觉恢复正常。女孩的异常步态似乎已成为永久性的,她走路时腿抬得比正常时更高。
据我们所知,这是首例关于迟发性CblC障碍患儿孤立性SCD的2例报告。医生应考虑SCD可能是CblC障碍的孤立症状。治疗越早,出现后遗症的可能性越低。